Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hay

Showing results (111-120 of 654) with videos related to

Pageof 66
Sort By:
Pediatrics|December 13, 2016
Modern Management of Preterm Infants Prevents Adverse Developmental Outcomes From HypoglycemiaPaul J Rozance, William W Hay
Clinical Chemistry|March 1, 1983
The "eyetone" blood glucose reflectance colorimeter evaluated for in vitro and in vivo accuracy and clinical efficacyW W Hay, I M Osberg
The Journal of Pediatrics|July 20, 2012
Neonatal hypoglycemia--answers, but more questionsPaul J Rozance, William W Hay
Pharmacoeconomics|March 8, 2005
Cost effectiveness of treating low HDL-cholesterol in the primary prevention of coronary heart diseaseJoel W Hay, Kimberly L Sterling
Journal of Clinical Gastroenterology|June 1, 1992
Inflammatory bowel disease: costs-of-illnessJ W Hay, A R Hay
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 6, 2006
A direction for Value in HealthJ W Hay, R L Ernst
Neonatology|January 23, 2019
Alert Newborn Infants Are Ready to Feed and Raise Their Glucose ConcentrationWilliam W Hay, Paul J Rozance
Quarterly Journal of Experimental Physiology (Cambridge, England)|October 1, 1986
The effect of hyperinsulinaemia on glucose utilization and oxidation and on oxygen consumption in the fetal lambW W Hay, H K Meznarich
Gynecologic Oncology|January 28, 2014
Cost-effectiveness of adding bevacizumab to first line therapy for patients with advanced ovarian cancerDarshan A Mehta, Joel W Hay
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 6, 2006
Introduction to the ISPOR Lipid ConferenceJ W Hay, J S Schwartz
Pageof 66

Showing results (111-120 of 654) with videos related to

Sort By:
Pageof 66
Pediatrics|December 13, 2016
Modern Management of Preterm Infants Prevents Adverse Developmental Outcomes From HypoglycemiaPaul J Rozance, William W Hay
Clinical Chemistry|March 1, 1983
The "eyetone" blood glucose reflectance colorimeter evaluated for in vitro and in vivo accuracy and clinical efficacyW W Hay, I M Osberg
The Journal of Pediatrics|July 20, 2012
Neonatal hypoglycemia--answers, but more questionsPaul J Rozance, William W Hay
Pharmacoeconomics|March 8, 2005
Cost effectiveness of treating low HDL-cholesterol in the primary prevention of coronary heart diseaseJoel W Hay, Kimberly L Sterling
Journal of Clinical Gastroenterology|June 1, 1992
Inflammatory bowel disease: costs-of-illnessJ W Hay, A R Hay
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 6, 2006
A direction for Value in HealthJ W Hay, R L Ernst
Neonatology|January 23, 2019
Alert Newborn Infants Are Ready to Feed and Raise Their Glucose ConcentrationWilliam W Hay, Paul J Rozance
Quarterly Journal of Experimental Physiology (Cambridge, England)|October 1, 1986
The effect of hyperinsulinaemia on glucose utilization and oxidation and on oxygen consumption in the fetal lambW W Hay, H K Meznarich
Gynecologic Oncology|January 28, 2014
Cost-effectiveness of adding bevacizumab to first line therapy for patients with advanced ovarian cancerDarshan A Mehta, Joel W Hay
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 6, 2006
Introduction to the ISPOR Lipid ConferenceJ W Hay, J S Schwartz
Pageof 66